AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DEXKETOPROFEN

11 registrations across 5 African markets— 10 active

Markets with DEXKETOPROFEN

Recent registrations

Brand / ProductMarketHolderStatusExpires
SERTOFEN 1.25% GEL
GEL
🇷🇼RwandaWORLD MEDICINE ILAC SAN. VE TIC.A.SactiveMay 2030
KETESSE 50MG/2ML SOLUTION INJECTABLE IM OU POUR PERFUSION IV BOITE DE 1🇨🇮Côte d'IvoireMENARINI INTERNATIONALexpiredJul 2025
KETESSE 25 mg🇿🇦South AfricaMenarini South Africa (Pty) LtdactiveJan 1900
SKUDEXA🇿🇦South AfricaMenarini South Africa (Pty) LtdactiveJan 1900
LENIZAK🇿🇦South AfricaMenarini South Africa (Pty) LtdactiveJan 1900
KERAL 25 mg🇿🇦South AfricaMenarini South Africa (Pty) LtdactiveJan 1900
INFEN-25
comprimé / 25 mg
🇸🇳SenegalEMCUREactive
INFEN-25
comprimé / 25 mg
🇸🇳SenegalEMCUREactive
Ketesse
Solution for injection
🇹🇿TanzaniaMenarini International Operations Luxembourg S.Aactive
Infen - 25
Tablets
🇹🇿TanzaniaEmcure Pharmaceuticals Ltdactive
Ketesse
Tablets
🇹🇿TanzaniaMenarini International Operations Luxembourg S.Aactive

DEXKETOPROFEN in Africa — Regulatory Overview

DEXKETOPROFEN is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Senegal, Côte d'Ivoire and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 10 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.